APA (7th ed.) Citation

von Wyl, V., Benkert, P., Moser, A., Lorscheider, J., Décard, B., Hänni, P., . . . Yaldizli, Ö. (2021). Disability progression in relapse-free multiple sclerosis patients on fingolimod versus interferon-beta/glatiramer acetate. Multiple Sclerosis Journal, 27(3), 439. https://doi.org/10.1177/1352458520918489

Chicago Style (17th ed.) Citation

von Wyl, Viktor, et al. "Disability Progression in Relapse-free Multiple Sclerosis Patients on Fingolimod Versus Interferon-beta/glatiramer Acetate." Multiple Sclerosis Journal 27, no. 3 (2021): 439. https://doi.org/10.1177/1352458520918489.

MLA (9th ed.) Citation

von Wyl, Viktor, et al. "Disability Progression in Relapse-free Multiple Sclerosis Patients on Fingolimod Versus Interferon-beta/glatiramer Acetate." Multiple Sclerosis Journal, vol. 27, no. 3, 2021, p. 439, https://doi.org/10.1177/1352458520918489.